Underwriting Agreements in the Biotechnology Industry
2,242 Contracts & Agreements
- 2seventy bio, Inc. (1 contract)
- 4D Molecular Therapeutics Inc (4)
- 89bio, Inc. (6)
- AbbVie Inc. (6)
- ABEONA THERAPEUTICS INC. (6)
- ACADIA PHARMACEUTICALS INC (6)
- ACCELERON PHARMA INC (6)
- Accustem Sciences Inc. (1)
- Achaogen, Inc. (4)
- ACHIEVE LIFE SCIENCES, INC. (9)
- Acorda Therapeutics (5)
- Actinium Pharmaceuticals, Inc. (4)
- Acumen Pharmaceuticals, Inc. (2)
- Acurx Pharmaceuticals, LLC (2)
- Adagio Therapeutics, Inc. (1)
- Adamas Pharmaceuticals Inc (4)
- Adaptimmune Therapeutics PLC (3)
- Adhera Therapeutics, Inc. (7)
- ADiTx Therapeutics, Inc. (6)
- ADMA BIOLOGICS, INC. (10)
- ADURO BIOTECH, INC. (3)
- Advaxis, Inc. (10)
- Adverum Biotechnologies, Inc. (5)
- Aeglea BioTherapeutics, Inc. (5)
- Aerovate Therapeutics, Inc. (1)
- AGENUS INC (3)
- AGIOS PHARMACEUTICALS INC (7)
- AILERON THERAPEUTICS INC (2)
- Aimmune Therapeutics, Inc. (2)
- AKCEA THERAPEUTICS, INC. (1)
- Akebia Therapeutics, Inc. (6)
- Akero Therapeutics, Inc. (5)
- Akouos, Inc. (1)
- ALBIREO PHARMA, INC. (9)
- Aldeyra Therapeutics, Inc. (9)
- Alector, Inc. (4)
- Alexion Pharmaceuticals (1)
- Aligos Therapeutics, Inc. (2)
- Alkermes plc. (1)
- Allakos Inc. (4)
- Allena Pharmaceuticals, Inc. (3)
- Alliqua BioMedical, Inc. (2)
- Allogene Therapeutics, Inc. (2)
- Allovir, Inc. (2)
- ALNYLAM PHARMACEUTICALS, INC. (9)
- Alpha Healthcare Acquisition Corp. (3)
- ALPINE IMMUNE SCIENCES, INC. (3)
- Altimmune, Inc. (2)
- ALX ONCOLOGY HOLDINGS INC (3)
- Alzamend Neuro, Inc. (1)
- AMARILLO BIOSCIENCES INC (2)
- AMARIN CORP PLC (7)
- Amgen Inc. (18)
- AMICUS THERAPEUTICS, INC. (7)
- AmpliPhi Biosciences Corp (4)
- Amplitude Healthcare Acquisition Corp (4)
- ANAPTYSBIO INC (3)
- Anchiano Therapeutics Ltd. (2)
- Anixa Biosciences Inc (1)
- Annexon, Inc. (2)
- Annovis Bio, Inc. (4)
- Apellis Pharmaceuticals, Inc. (7)
- APPLIED GENETIC TECHNOLOGIES CORP (6)
- Applied Molecular Transport Inc. (2)
- Applied Therapeutics Inc. (4)
- Aprea Therapeutics, Inc. (2)
- Aptevo Therapeutics Inc. (1)
- Aptinyx Inc. (2)
- Aptose Biosciences Inc. (6)
- AquaBounty Technologies, Inc. (10)
- AQUINOX PHARMACEUTICALS, INC (5)
- Aravive, Inc. (3)
- Arbutus Biopharma Corp (1)
- ARCA biopharma, Inc. (1)
- Arcellx, Inc. (2)
- Arcturus Therapeutics Holdings Inc. (3)
- Arcus Biosciences, Inc. (2)
- Arcutis Biotherapeutics, Inc. (6)
- ARDELYX, INC. (4)
- ARENA PHARMACEUTICALS INC (7)
- Aridis Pharmaceuticals, Inc. (1)
- ARROWHEAD PHARMACEUTICALS, INC. (3)
- Arsanis, Inc. (4)
- Artiva Biotherapeutics, Inc. (1)
- ARYA Sciences Acquisition Corp II (5)
- ASSEMBLY BIOSCIENCES, INC. (8)
- Atara Biotherapeutics, Inc. (8)
- Athenex, Inc. (3)
- ATHERSYS, INC (2)
- ATOSSA GENETICS INC (7)
- Atreca, Inc. (2)
- aTYR PHARMA INC (3)
- Aura Biosciences, Inc. (3)
- AVEO PHARMACEUTICALS INC (5)
- Avid Bioservices, Inc. (3)
- Avidity Biosciences, Inc. (3)
- Avita Therapeutics, Inc. (1)
- AVROBIO, Inc. (4)
- Axcella Health Inc. (2)
- Axovant Sciences Ltd. (5)
- Ayala Pharmaceuticals, Inc. (2)
- AZIYO BIOLOGICS, INC. (2)
- AzurRx BioPharma, Inc. (4)
- BCTG Acquisition Corp. (2)
- Beam Therapeutics Inc. (2)
- BeiGene, Ltd. (7)
- BELLICUM PHARMACEUTICALS, INC (5)
- Benitec Biopharma Inc. (7)
- BICYCLE THERAPEUTICS Ltd (3)
- Big Cypress Acquisition Corp. (2)
- BIO-PATH HOLDINGS INC (1)
- bioAffinity Technologies, Inc. (18)
- BioAtla, Inc. (2)
- BioCardia, Inc. (4)
- BIOCEPT INC (8)
- BIOCRYST PHARMACEUTICALS INC (8)
- Biogen Inc. (2)
- Biohaven Pharmaceutical Holding Co Ltd. (5)
- BioLife4D Corp (4)
- BIOMARIN PHARMACEUTICAL INC (6)
- Biomea Fusion, Inc. (2)
- BioNexus Gene Lab Coporation (2)
- BioRestorative Therapies, Inc. (5)
- Biostage, Inc. (2)
- BIOTIME INC (5)
- BIOVIE INC. (4)
- BioXcel Therapeutics, Inc. (5)
- Bison Capital Acquisition Corp. (2)
- Black Diamond Therapeutics, Inc. (2)
- Blue Water Vaccines Inc. (3)
- bluebird bio, Inc. (11)
- Blueprint Medicines Corp (6)
- Bolt Biotherapeutics, Inc. (1)
- Bone Biologics Corp (9)
- BRAINSTORM CELL THERAPEUTICS INC. (2)
- BridgeBio Pharma, Inc. (4)
- BullFrog AI Holdings, Inc. (5)
- C4 Therapeutics, Inc. (2)
- Cabaletta Bio, Inc. (3)
- CALADRIUS BIOSCIENCES, INC. (5)
- Calithera Biosciences, Inc. (5)
- Calyxt, Inc. (5)
- CANCER GENETICS, INC (9)
- Candel Therapeutics, Inc. (1)
- CAPRICOR THERAPEUTICS, INC. (1)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
- CareDx, Inc. (5)
- Caribou Biosciences, Inc. (2)
- CASTLE BIOSCIENCES INC (3)
- CATABASIS PHARMACEUTICALS INC (9)
- CATALYST BIOSCIENCES, INC. (8)
- CATALYST PHARMACEUTICALS, INC. (9)
- CEL SCI CORP (9)
- Celcuity Inc. (2)
- Celldex Therapeutics, Inc. (9)
- Cellectar Biosciences, Inc. (7)
- Cellular Biomedicine Group, Inc. (1)
- Celsion CORP (3)
- Centessa Pharmaceuticals Ltd (1)
- Century Therapeutics, Inc. (1)
- Chanticleer Holdings, Inc. (11)
- Chardan Healthcare Acquisition 2 Corp. (2)
- Chardan Healthcare Acquisition Corp. (2)
- Checkmate Pharmaceuticals, Inc. (1)
- Checkpoint Therapeutics, Inc. (3)
- Chelsea Worldwide Inc. (1)
- ChemoCentryx, Inc. (3)
- CHIMERIX INC (7)
- Cibus Global, Ltd. (1)
- Cidara Therapeutics, Inc. (6)
- CLEVELAND BIOLABS INC (2)
- Clovis Oncology, Inc. (9)
- CM Life Sciences III Inc. (2)
- Codiak BioSciences, Inc. (3)
- CohBar, Inc. (2)
- Coherus BioSciences, Inc. (6)
- Conatus Pharmaceuticals Inc. (3)
- CONCERT PHARMACEUTICALS, INC. (4)
- Consonance-HFW Acquisition Corp. (2)
- Constellation Alpha Capital Corp. (6)
- CONSTELLATION PHARMACEUTICALS INC (3)
- CONTRAFECT Corp (6)
- Corbus Pharmaceuticals Holdings, Inc. (4)
- Cortexyme, Inc. (1)
- Corvus Pharmaceuticals, Inc. (3)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (3)
- Crinetics Pharmaceuticals, Inc. (6)
- CRISPR Therapeutics AG (5)
- CTD HOLDINGS INC (4)
- CTI BIOPHARMA CORP (7)
- Cue Biopharma, Inc. (1)
- Cullinan Oncology, LLC (1)
- Curative Biotechnology Inc (1)
- CURIS INC (3)
- Cyclacel Pharmaceuticals, Inc. (9)
- Cytokinetics, Incorporated (7)
- CytomX Therapeutics, Inc. (3)
- CYTORI THERAPEUTICS, INC. (4)
- CYTRX CORP (5)
- Day One Biopharmaceuticals Holding Co LLC (3)
- Decibel Therapeutics, Inc. (1)
- Deciphera Pharmaceuticals, Inc. (6)
- DelMar Pharmaceuticals, Inc. (3)
- Denali Therapeutics Inc. (3)
- Dermavant Sciences Ltd (1)
- Dermira, Inc. (5)
- Design Therapeutics, Inc. (1)
- DiaMedica Therapeutics Inc. (4)
- Dicerna Pharmaceuticals Inc (4)
- Diffusion Pharmaceuticals Inc. (4)
- Dynamics Special Purpose Corp. (2)
- DYNAVAX TECHNOLOGIES CORP (9)
- Dyne Therapeutics, Inc. (3)
- Edge Therapeutics, Inc. (4)
- Editas Medicine, Inc. (6)
- Eidos Therapeutics, Inc. (1)
- Eiger BioPharmaceuticals, Inc. (7)
- Elevation Oncology, Inc. (2)
- Eliem Therapeutics, Inc. (1)
- Enanta Pharmaceuticals, Inc. (1)
- Entasis Therapeutics Holdings Inc. (1)
- Entrada Therapeutics, Inc. (1)
- Environmental Impact Acquisition Corp (2)
- Epizyme, Inc. (9)
- Equillium, Inc. (2)
- Erasca, Inc. (2)
- Esperion Therapeutics, Inc. (3)
- ESSA Pharma Inc. (1)
- Evelo Biosciences, Inc. (2)
- EXACT SCIENCES CORP (4)
- Exelixis (8)
- EXICURE, INC. (2)
- FATE THERAPEUTICS INC (8)
- FENNEC PHARMACEUTICALS INC. (3)
- Fibrocell Science, Inc. (4)
- FIBROGEN INC (3)
- Finch Therapeutics Group, Inc. (1)
- FIVE PRIME THERAPEUTICS INC (5)
- Flex Pharma, Inc. (6)
- Flexion Therapeutics Inc (4)
- Foghorn Therapeutics Inc. (1)
- Forma Therapeutics Holdings, Inc., (2)
- Fortress Biotech, Inc. (8)
- Forty Seven, Inc. (3)
- Frequency Therapeutics, Inc. (1)
- FS Development Corp. (3)
- FS Development Corp. II (2)
- Fusion Pharmaceuticals Inc. (1)
- G1 Therapeutics, Inc. (4)
- Gain Therapeutics, Inc. (3)
- GALECTIN THERAPEUTICS INC (1)
- Galecto Inc. (1)
- Galera Therapeutics, Inc. (1)
- Gamida Cell Ltd. (2)
- Gemphire Therapeutics Inc. (5)
- GENELUX CORP (1)
- Generation Bio Co. (2)
- GENOCEA BIOSCIENCES, INC. (7)
- Genprex, Inc. (2)
- GeoVax Labs, Inc. (4)
- GERON CORP (8)
- Gilead Sciences (9)
- Global Blood Therapeutics, Inc. (6)
- GLYCOMIMETICS INC (4)
- Gossamer Bio, Inc. (4)
- Grail, Inc. (1)
- Graphite Bio, Inc. (2)
- Greenwich LifeSciences, Inc. (5)
- Gritstone Oncology, Inc. (3)
- GT Biopharma, Inc. (1)
- GTX INC (3)
- GX Acquisition Corp. (4)
- HALOZYME THERAPEUTICS INC (4)
- Harpoon Therapeutics, Inc. (2)
- HCW Biologics Inc. (1)
- Health Sciences Acquisitions Corp (6)
- HEAT BIOLOGICS, INC. (13)
- HEMISPHERX BIOPHARMA INC (2)
- HERON THERAPEUTICS, INC. (9)
- HilleVax, Inc. (2)
- Hillstream BioPharma Inc. (3)
- HISTOGENICS CORP (4)
- Homology Medicines, Inc. (3)
- HOOKIPA Pharma Inc. (4)
- HUMANIGEN, INC (4)
- iBio, Inc. (11)
- Icosavax, Inc. (1)
- IDEAYA Biosciences, Inc. (5)
- IDERA PHARMACEUTICALS, INC. (3)
- IGM Biosciences, Inc. (4)
- Imago BioSciences, Inc. (1)
- Immix Biopharma, Inc. (3)
- IMMUCELL CORP (2)
- IMMUNE PHARMACEUTICALS INC (2)
- Immuneering Corp (2)
- ImmunoCellular Therapeutics, Ltd. (9)
- IMMUNOGEN INC (8)
- Immunome Inc. (2)
- IMMUNOMEDICS INC (6)
- IMPEL NEUROPHARMA INC (2)
- IN8BIO, INC. (4)
- Incyte (3)
- INFINITY PHARMACEUTICALS, INC. (3)
- Inhibikase Therapeutics, Inc. (3)
- Inhibrx, Inc. (1)
- InMed Pharmaceuticals Inc. (3)
- Inmune Bio, Inc. (1)
- INOVIO PHARMACEUTICALS, INC. (3)
- Inozyme Pharma, Inc. (3)
- INSMED Inc (11)
- Inspyr Therapeutics, Inc. (1)
- Instil Bio, Inc. (1)
- Intec Pharma Ltd. (1)
- Intellia Therapeutics, Inc. (6)
- INTERCEPT PHARMACEUTICALS, INC. (7)
- INTREXON CORP (8)
- Intrinsic Medicine, Inc. (1)
- Invitae Corp (6)
- IONIS PHARMACEUTICALS INC (1)
- IOVANCE BIOTHERAPEUTICS, INC. (9)
- IRONWOOD PHARMACEUTICALS INC (5)
- Isoray, Inc. (5)
- iTeos Therapeutics, Inc. (1)
- Janux Therapeutics, Inc. (3)
- Jounce Therapeutics, Inc. (1)
- Kadmon Holdings, Inc. (3)
- KalVista Pharmaceuticals, Inc. (4)
- Karuna Therapeutics, Inc. (4)
- Karyopharm Therapeutics Inc. (6)
- KBL MERGER CORP. IV (1)
- Keros Therapeutics, Inc. (3)
- Kezar Life Sciences, Inc. (3)
- Kindred Biosciences, Inc. (6)
- Kiniksa Pharmaceuticals, Ltd. (3)
- Kinnate Biopharma Inc. (1)
- Kiromic Biopharma, Inc. (4)
- Kodiak Sciences Inc. (3)
- Kronos Bio, Inc. (1)
- Krystal Biotech, Inc. (6)
- Kura Oncology, Inc. (7)
- Kymera Therapeutics, Inc. (3)
- LA JOLLA PHARMACEUTICAL CO (4)
- Lantern Pharma Inc. (2)
- LEAP THERAPEUTICS, INC. (4)
- Leisure Acquisition Corp. (4)
- LEXICON PHARMACEUTICALS, INC. (4)
- LianBio (1)
- LifeSci Acquisition Corp. (2)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
- Locust Walk Acquisition Corp. (2)
- LogicBio Therapeutics, Inc. (2)
- LONGEVERON LLC (2)
- Lyell Immunopharma, Inc. (1)
- MACROGENICS INC (5)
- MADRIGAL PHARMACEUTICALS, INC. (9)
- Magenta Therapeutics, Inc. (4)
- MAIA Biotechnology, Inc. (8)
- MANNKIND CORP (4)
- MARIZYME INC (2)
- Marker Therapeutics, Inc. (1)
- MATEON THERAPEUTICS INC (1)
- Matinas BioPharma Holdings, Inc. (2)
- MAXCYTE, INC. (1)
- MEDICINOVA INC (4)
- Medovex Corp. (6)
- MEI Pharma, Inc. (5)
- MeiraGTx Holdings plc (3)
- MERRIMACK PHARMACEUTICALS INC (3)
- Mersana Therapeutics, Inc. (3)
- Merus N.V. (3)
- Metacrine, Inc. (1)
- Millendo Therapeutics, Inc. (4)
- MiMedx Group, Inc. (1)
- Minerva Neurosciences, Inc. (3)
- MiNK Therapeutics, Inc. (1)
- MIRAGEN THERAPEUTICS, INC. (7)
- Mirati Therapeutics, Inc. (13)
- Mirum Pharmaceuticals, Inc. (4)
- Moderna, Inc. (3)
- Molecular Templates, Inc. (5)
- Moleculin Biotech, Inc. (5)
- Momenta Pharmaceuticals, Inc. (5)
- Monopar Therapeutics (1)
- Monte Rosa Therapeutics, Inc. (1)
- Morphic Holding, Inc. (3)
- MUSTANG BIO, INC. (2)
- Myovant Sciences Ltd. (3)
- Myriad Genetics, Inc. (1)
- NANOVIRICIDES, INC. (3)
- NantKwest, Inc. (2)
- Natera, Inc. (8)
- NAVIDEA BIOPHARMACEUTICALS, INC. (3)
- NEUROBIOLOGICAL TECHNOLOGIES INC (1)
- NEUROCRINE BIOSCIENCES INC (4)
- NEWLINK GENETICS CORP (3)
- NexImmune, Inc. (1)
- NextCure, Inc. (2)
- Nkarta, Inc. (3)
- NORTHWEST BIOTHERAPEUTICS INC (3)
- NOVAVAX INC (6)
- Novus Therapeutics, Inc. (1)
- NTN BUZZTIME INC (1)
- Nurix Therapeutics, Inc. (3)
- Nuvalent, Inc. (3)
- Nuvectis Pharma, Inc. (3)
- Ohr Pharmaceutical Inc (3)
- Olema Pharmaceuticals, Inc. (1)
- Olivia Ventures, Inc. (2)
- Omega Therapeutics, Inc. (1)
- OncoCyte Corp (1)
- Oncorus, Inc. (2)
- ONCOSEC MEDICAL Inc (2)
- OPGEN INC (5)
- Ophthotech Corp. (7)
- Opko Health, Inc. (2)
- ORAGENICS INC (7)
- Organogenesis Holdings Inc. (3)
- ORGANOVO HOLDINGS, INC. (3)
- Oric Pharmaceuticals, Inc. (2)
- Outlook Therapeutics, Inc. (6)
- Ovid Therapeutics Inc. (6)
- Oyster Point Pharma, Inc. (2)
- PALATIN TECHNOLOGIES INC (2)
- Pasithea Therapeutics Corp. (2)
- Passage BIO, Inc. (2)
- PDL BIOPHARMA, INC. (4)
- PepGen Inc. (2)
- Petra Acquisition Inc. (5)
- Pfenex Inc. (4)
- PharmaCyte Biotech, Inc. (1)
- PhaseBio Pharmaceuticals Inc (3)
- Phio Pharmaceuticals Corp. (7)
- PIERIS PHARMACEUTICALS, INC. (2)
- PLURISTEM THERAPEUTICS INC (5)
- PMV Pharmaceuticals, Inc. (1)
- POLARITYTE, INC. (5)
- PORTOLA PHARMACEUTICALS INC (7)
- Poseida Therapeutics, Inc. (1)
- Praxis Precision Medicines, Inc. (3)
- PRECISION BIOSCIENCES INC (3)
- Prelude Therapeutics Inc (3)
- Prevail Therapeutics Inc. (1)
- Principia Biopharma Inc. (2)
- Progenics Pharmaceuticals, Inc. (7)
- PROGENITY, INC. (3)
- Prometheus Biosciences, Inc. (2)
- Protagenic Therapeutics, Inc. (2)
- Protagonist Therapeutics, Inc (6)
- Protalix BioTherapeutics, Inc. (3)
- PROTEON THERAPEUTICS INC (3)
- PROTEOSTASIS THERAPEUTICS, INC. (4)
- Prothena Corp plc (8)
- PTC THERAPEUTICS, INC. (6)
- PUMA BIOTECHNOLOGY, INC. (4)
- Pyxis Oncology, Inc. (1)
- Radius Health, Inc. (6)
- Rallybio Corp (2)
- RAPT Therapeutics, Inc. (5)
- RECURSION PHARMACEUTICALS, INC. (1)
- Regeneron Pharmaceuticals (4)
- REGENXBIO Inc. (5)
- Regulus Therapeutics Inc. (4)
- Relay Therapeutics, Inc. (3)
- Reneo Pharmaceuticals, Inc. (2)
- RenovoRx, Inc. (2)
- Repare Therapeutics Inc. (1)
- Replimune Group, Inc. (4)
- Retrophin, Inc. (7)
- Revolution Medicines, Inc. (5)
- REXAHN PHARMACEUTICALS, INC. (2)
- Rezolute, Inc. (2)
- RHYTHM PHARMACEUTICALS, INC. (5)
- RIGEL PHARMACEUTICALS INC (9)
- RITTER PHARMACEUTICALS INC (2)
- ROCKET PHARMACEUTICALS, INC. (11)
- Rubius Therapeutics, Inc. (2)
- Sage Therapeutics, Inc. (7)
- Sana Biotechnology, Inc. (2)
- SANGAMO THERAPEUTICS, INC (6)
- Sarepta Therapeutics, Inc. (7)
- Savara Inc (8)
- Scholar Rock Holding Corp (3)
- SEATTLE GENETICS INC (4)
- SELECTA BIOSCIENCES INC (3)
- SELLAS Life Sciences Group, Inc. (13)
- Sensei Biotherapeutics, Inc. (1)
- SERA PROGNOSTICS, INC. (1)
- Seres Therapeutics, Inc. (3)
- Sesen Bio, Inc. (6)
- Shattuck Labs, Inc. (2)
- Shuttle Pharmaceuticals Holdings, Inc. (6)
- Sierra Oncology, Inc. (5)
- Sigilon Therapeutics, Inc. (1)
- Silverback Therapeutics, Inc. (1)
- Social Capital Suvretta Holdings Corp. III (2)
- SOLENO THERAPEUTICS INC (10)
- Solid Biosciences Inc. (2)
- SOLIGENIX, INC. (2)
- SOPHIRIS BIO INC. (1)
- Sorrento Therapeutics, Inc. (4)
- Spectrum Pharmaceuticals, Inc. (1)
- Spero Therapeutics, Inc. (4)
- SPHERIX INC (4)
- Spinning Eagle Acquisition Corp. (3)
- Spring Bank Pharmaceuticals, Inc. (5)
- SpringWorks Therapeutics, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (1)
- SQZ Biotechnologies Co (2)
- Stellar Biotechnologies, Inc. (1)
- Stoke Therapeutics, Inc. (3)
- Sun BioPharma, Inc. (5)
- SUNESIS PHARMACEUTICALS INC (13)
- Sunshine Biopharma, Inc (5)
- Surface Oncology, Inc. (1)
- SUTRO BIOPHARMA, INC. (4)
- Syndax Pharmaceuticals Inc (7)
- SYNLOGIC, INC. (6)
- Synthetic Biologics, Inc. (6)
- Syros Pharmaceuticals, Inc. (6)
- T2 Biosystems, Inc. (5)
- Talaris Therapeutics, Inc. (2)
- Taysha Gene Therapies, Inc. (3)
- TCR2 THERAPEUTICS INC. (3)
- TENAX THERAPEUTICS, INC. (2)
- Tenaya Therapeutics, Inc. (3)
- TG THERAPEUTICS, INC. (4)
- Therapeutics Acquisition Corp. (3)
- Tocagen Inc (3)
- Tonix Pharmaceuticals Holding Corp. (16)
- Tracon Pharmaceuticals, Inc. (3)
- Transcode Therapeutics, Inc. (5)
- Translate Bio, Inc. (3)
- TREVENA INC (4)
- Trovagene, Inc. (4)
- TScan Therapeutics, Inc. (2)
- Turning Point Therapeutics, Inc. (4)
- Twist Bioscience Corp (6)
- TYME TECHNOLOGIES, INC. (2)
- Tyra Biosciences, Inc. (1)
- U.S. Stem Cell, Inc. (1)
- Ultragenyx Pharmaceutical Inc. (8)
- Unicycive Therapeutics, Inc. (2)
- uniQure N.V. (3)
- Unity Biotechnology, Inc. (2)
- Unum Therapeutics Inc. (5)
- UroGen Pharma Ltd. (1)
- VACCINEX, INC. (1)
- Vaccitech plc (1)
- Vanda Pharmaceuticals Inc. (3)
- Vaxart, Inc. (3)
- Vaxcyte, Inc. (5)
- Vaxxinity, Inc. (2)
- VBI Vaccines Inc (5)
- Vera Therapeutics, Inc. (4)
- VERACYTE, INC. (7)
- Verastem, Inc. (6)
- Vericel Corp (8)
- Vertex Pharmaceuticals Inc (4)
- Verve Therapeutics, Inc. (3)
- VICAL INC (7)
- Viela Bio, Inc. (2)
- Vigil Neuroscience, Inc. (1)
- Viking Therapeutics, Inc. (9)
- Vir Biotechnology, Inc. (2)
- Virios Therapeutics, LLC (2)
- VistaGen Therapeutics, Inc. (8)
- VITAL THERAPIES INC (6)
- VITRO DIAGNOSTICS INC (1)
- Vor Biopharma Inc. (2)
- Voyager Therapeutics, Inc. (3)
- vTv Therapeutics Inc. (1)
- Werewolf Therapeutics, Inc. (1)
- WINDTREE THERAPEUTICS INC (9)
- XBiotech Inc. (1)
- Xencor Inc (4)
- Xenetic Biosciences, Inc. (4)
- Xenon Pharmaceuticals Inc. (8)
- Xilio Therapeutics, Inc. (1)
- XOMA Corp (6)
- Y-mAbs Therapeutics, Inc. (2)
- YIELD10 BIOSCIENCE, INC. (13)
- Yulong Eco-Materials Ltd (2)
- ZAFGEN, INC. (5)
- Zai Lab Ltd (2)
- Zentalis Pharmaceuticals, LLC (5)
- ZIOPHARM ONCOLOGY INC (6)
- Zymeworks Inc. (2)
- Underwriting Agreement by and among Nurix Therapeutics, Inc. and J.P. Morgan Securities LLC, Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated as Representatives of... (Nurix Therapeutics, Inc., Filed With SEC on April 12, 2024)
- Underwriting Agreement, dated April 1, 2024 (Gritstone Oncology, Inc., Filed With SEC on April 2, 2024)
- Underwriting Agreement dated April 2, 2024 (SUTRO BIOPHARMA, INC., Filed With SEC on April 2, 2024)
- Underwriting Agreement, dated March 25, 2024, among Nkarta, Inc., Leerink Partners LLC and Cowen and Company, LLC, as representatives of the several underwriters named therein (Nkarta, Inc., Filed With SEC on March 28, 2024)
- Underwriting Agreement dated March 27, 2024, by and between the Company and J.P. Morgan Securities LLC (Stoke Therapeutics, Inc., Filed With SEC on March 28, 2024)
- Underwriting Agreement, dated as of March 19, 2024, among Fate Therapeutics, Inc., BofA Securities, Inc., Jefferies LLC and Leerink Partners LLC, as representatives of the... (FATE THERAPEUTICS INC, Filed With SEC on March 21, 2024)
- Underwriting Agreement, dated March 19, 2024, by and among Geron Corporation and Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the... (GERON CORP, Filed With SEC on March 20, 2024)
- Underwriting Agreement, dated March 18, 2024 (MADRIGAL PHARMACEUTICALS, INC., Filed With SEC on March 20, 2024)
- Underwriting Agreement, dated March 6, 2024, among REGENXBIO Inc. and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Barclays Capital Inc. and Stifel, Nicolaus & Company,... (REGENXBIO Inc., Filed With SEC on March 11, 2024)
- Underwriting Agreement dated March 7, 2024 (HEAT BIOLOGICS, INC., Filed With SEC on March 11, 2024)
- Underwriting Agreement, dated as of March 5, 2024, by and between the Company, J.P. Morgan, Morgan Stanley, Jefferies, and Evercore, as representatives of the several underwriters... (Akero Therapeutics, Inc., Filed With SEC on March 6, 2024)
- Underwriting Agreement, dated as of March 5, 2024, by and among the Company, J.P. Morgan Securities LLC, Cantor Fitzgerald & Co. and Mizuho Securities USA LLC, as representatives... (BridgeBio Pharma, Inc., Filed With SEC on March 6, 2024)
- Underwriting Agreement, dated February 29, 2024, by and among Humacyte, Inc., and Cowen and Company, LLC and Cantor Fitzgerald & Co. as representatives of the Underwriters (Alpha Healthcare Acquisition Corp., Filed With SEC on March 4, 2024)
- Underwriting Agreement, dated February 28, 2024, by and among Arcutis Biotherapeutics, Inc. and (Arcutis Biotherapeutics, Inc., Filed With SEC on March 4, 2024)
- Underwriting Agreement, dated February 29, 2024, by and among Celldex Therapeutics, Inc. and Leerink Partners LLC and Cowen and Company, LLC, as representatives of the several... (Celldex Therapeutics, Inc., Filed With SEC on March 1, 2024)
- Underwriting Agreement, dated as of February 28, 2024, by and among Viking Therapeutics, Inc. and Morgan Stanley & Co. LLC and Leerink Partners LLC, as representatives of the... (Viking Therapeutics, Inc., Filed With SEC on March 1, 2024)
- Underwriting Agreement, dated March 1, 2024, between the Company and Guggenheim Securities, LLC (PRECISION BIOSCIENCES INC, Filed With SEC on March 1, 2024)
- Underwriting Agreement dated February 27, 2024 between Oragenics, Inc. and ThinkEquity LLC (ORAGENICS INC, Filed With SEC on March 1, 2024)
- Underwriting Agreement, dated February 28, 2024, by and among Janux Therapeutics, Inc. and BofA Securities, Inc., Cowen and Company, LLC, Cantor Fitzgerald & Co. and William Blair... (Janux Therapeutics, Inc., Filed With SEC on February 29, 2024)
- Underwriting Agreement, dated February 22, 2024, by and among AbbVie Inc., Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets... (AbbVie Inc., Filed With SEC on February 26, 2024)
- Underwriting Agreement, dated as of February 20, 2024 among Iovance Biotherapeutics, Inc., Jefferies LLC, Barclays Capital Inc. and Goldman Sachs & Co. LLC (IOVANCE BIOTHERAPEUTICS, INC., Filed With SEC on February 20, 2024)
- Underwriting Agreement, dated February 14, 2024, by and among the Company, Leerink Partners LLC, Citigroup Global Markets Inc. and Guggenheim Securities, LLC, as representatives... (ZAFGEN, INC., Filed With SEC on February 16, 2024)
- Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, Leerink Partners LLC, Stifel Nicolaus & Company, Incorporated, and Cantor Fitzgerald & Co.,... (KalVista Pharmaceuticals, Inc., Filed With SEC on February 16, 2024)
- Underwriting Agreement, dated February 13, 2024, by and between the Company and Aegis Capital Corp (Sunshine Biopharma, Inc, Filed With SEC on February 15, 2024)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC, Leerink Partners LLC, and Guggenheim Securities, LLC, dated February 13, 2024 (Immunome Inc., Filed With SEC on February 14, 2024)
- Underwriting Agreement dated as of February 8, 2024, by and between CEL-SCI Corporation and ThinkEquity, LLC (CEL SCI CORP, Filed With SEC on February 13, 2024)
- Underwriting Agreement, dated as of February 6, 2024, among 4D Molecular Therapeutics, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc., Jefferies LLC and Barclays Capital... (4D Molecular Therapeutics Inc, Filed With SEC on February 9, 2024)
- Form of Underwriting Agreement (Sunshine Biopharma, Inc, Filed With SEC on February 9, 2024)
- Underwriting Agreement between the Company, Leerink Partners LLC and Cowen and Company, LLC, dated as of February 7, 2024 (Tenaya Therapeutics, Inc., Filed With SEC on February 8, 2024)
- Underwriting Agreement, dated as of February 7, 2024, among Sana Biotechnology, Inc. and the Representatives (Sana Biotechnology, Inc., Filed With SEC on February 8, 2024)
- Underwriting Agreement dated February 6, 2024 (PepGen Inc., Filed With SEC on February 7, 2024)
- Underwriting Agreement dated as of February 5, 2024 between the Company and Titan Partners Group LLC (Immix Biopharma, Inc., Filed With SEC on February 6, 2024)
- Underwriting Agreement, dated as January 31, 2024, among Bullfrog Ai Holdings, Inc. and the Representative (BullFrog AI Holdings, Inc., Filed With SEC on February 6, 2024)
- Underwriting Agreement, dated as of February 6, 2024, by and among Jasper Therapeutics, Inc., Cowen and Company, LLC and Evercore Group L.L.C (Amplitude Healthcare Acquisition Corp, Filed With SEC on February 6, 2024)
- Underwriting Agreement, dated January 31, 2024 (Corbus Pharmaceuticals Holdings, Inc., Filed With SEC on February 1, 2024)
- Underwriting Agreement, dated January 30, 2024 (Vaxcyte, Inc., Filed With SEC on January 31, 2024)
- Underwriting Agreement, dated January 30, 2024, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (CATABASIS PHARMACEUTICALS INC, Filed With SEC on January 31, 2024)
- Underwriting Agreement (Aptose Biosciences Inc., Filed With SEC on January 30, 2024)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., dated January 29, 2024 (Vera Therapeutics, Inc., Filed With SEC on January 30, 2024)
- Form of Underwriting Agreement (BullFrog AI Holdings, Inc., Filed With SEC on January 29, 2024)